Current Opinion in Virology

1

Do persistent RNA viruses fit the trade-off hypothesis of virulence evolution?

Luis M Márquez, Marilyn J Roossinck

Journal:

Year:

2012

Language:

english

File:

PDF, 254 KB

english, 2012

2

The use of oncolytic viruses to overcome lung cancer drug resistance

Vladimir Beljanski, John Hiscott

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 819 KB

english, 2012

3

Closing the gap: the challenges in converging theoretical, computational, experimental and real-life studies in virus evolution

Marco Vignuzzi, Raul Andino

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 184 KB

english, 2012

4

Implications of altered replication fidelity on the evolution and pathogenesis of coronaviruses

Everett C Smith, Mark R Denison

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 578 KB

english, 2012

5

RNA virus genetic robustness: possible causes and some consequences

Santiago F Elena

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 485 KB

english, 2012

6

Modelling viral evolution and adaptation: challenges and rewards

Susanna C Manrubia

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 873 KB

english, 2012

7

Viral fitness: definitions, measurement, and current insights

Andrew R Wargo, Gael Kurath

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 358 KB

english, 2012

8

Virus population bottlenecks during within-host progression and host-to-host transmission

Serafín Gutiérrez, Yannis Michalakis, Stéphane Blanc

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 610 KB

english, 2012

9

A cross-species view on viruses

Sara L Sawyer, Nels C Elde

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 702 KB

english, 2012

10

The future of integrase inhibitors of HIV-1

Isabelle Malet, Vincent Calvez, Anne-Geneviève Marcelin

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 634 KB

english, 2012

11

Direct-acting and host-targeting HCV inhibitors: current and future directions

Laurent Chatel-Chaix, Marie-Anne Germain, Matthias Götte, Daniel Lamarre

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 506 KB

english, 2012

12

Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure

Zabrina L Brumme, Denis R Chopera, Mark A Brockman

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 568 KB

english, 2012

13

New horizons for antiviral drug discovery from virus–host protein interaction networks

Benoît de Chassey, Laurène Meyniel-Schicklin, Anne Aublin-Gex, Patrice André, Vincent Lotteau

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 618 KB

english, 2012

14

Regulators of innate immunity as novel targets for panviral therapeutics

Salwa Es-Saad, Nicolas Tremblay, Martin Baril, Daniel Lamarre

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 635 KB

english, 2012

15

Are subtype differences important in HIV drug resistance?

RJ Lessells, DK Katzenstein, T de Oliveira

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 424 KB

english, 2012

16

The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance

Matthias Götte

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 589 KB

english, 2012

17

Clinical relevance of HCV antiviral drug resistance

C Welsch, S Zeuzem

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 491 KB

english, 2012

18

The development of novel HIV integrase inhibitors and the problem of drug resistance

Mark A Wainberg, Thibault Mesplède, Peter K Quashie

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 307 KB

english, 2012

19

Human viral diseases: what is next for antiviral drug discovery?

Erik De Clercq

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 303 KB

english, 2012

20

Staying ahead of viruses: a never ending task

Daniel Lamarre, Mark A Wainberg

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 162 KB

english, 2012

21

Virus–host interactomes — antiviral drug discovery

Yue Ma-Lauer, Jian Lei, Rolf Hilgenfeld, Albrecht von Brunn

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 667 KB

english, 2012

22

Editorial Board

Journal:

Current Opinion in Virology

Year:

2012

Language:

english

File:

PDF, 46 KB

english, 2012

23

Volume 2; Issue 5

Do persistent RNA viruses fit the trade-off hypothesis of virulence evolution?

The use of oncolytic viruses to overcome lung cancer drug resistance

Closing the gap: the challenges in converging theoretical, computational, experimental and real-life studies in virus evolution

Implications of altered replication fidelity on the evolution and pathogenesis of coronaviruses

RNA virus genetic robustness: possible causes and some consequences

Modelling viral evolution and adaptation: challenges and rewards

Viral fitness: definitions, measurement, and current insights

Virus population bottlenecks during within-host progression and host-to-host transmission

A cross-species view on viruses

The future of integrase inhibitors of HIV-1

Direct-acting and host-targeting HCV inhibitors: current and future directions

Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure

New horizons for antiviral drug discovery from virus–host protein interaction networks

Regulators of innate immunity as novel targets for panviral therapeutics

Are subtype differences important in HIV drug resistance?

The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance

Clinical relevance of HCV antiviral drug resistance

The development of novel HIV integrase inhibitors and the problem of drug resistance

Human viral diseases: what is next for antiviral drug discovery?

Staying ahead of viruses: a never ending task

Virus–host interactomes — antiviral drug discovery

Editorial Board

Contents